TRIMBOW® and RELVAR® on Lung Stiffness Reduction Assessed Through Forced Oscillation Technique in Patients With COPD
Status:
Withdrawn
Trial end date:
2022-02-18
Target enrollment:
Participant gender:
Summary
Efficacy of TRIMBOW® pMDI and RELVAR® ELLIPTA® DPI on lung stiffness reduction assessed
through area under the reactance curve (AX) using oscillometry in chronic obstructive
pulmonary disease (COPD).